Subscribe To
NMRA / Neumora Therapeutics to Participate in Upcoming Conferences in November
NMRA News
By GlobeNewsWire
October 30, 2023
Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining n more_horizontal
By The Motley Fool
September 21, 2023
Why Shares of Neumora Therapeutics Slumped This Week
Neumora focuses on central nervous system disorders. Its lead therapy is Navacaprant to treat MDD. more_horizontal